Literature DB >> 12597419

Clinical, clinicopathologic, and radiographic findings in dogs with coccidioidomycosis: 24 cases (1995-2000).

Lynelle R Johnson1, Eric J Herrgesell, Autumn P Davidson, Demosthenes Pappagianis.   

Abstract

OBJECTIVE: To determine clinical, clinicopathologic, and radiographic abnormalities in dogs with coccidioidomycosis.
DESIGN: Retrospective case series. ANIMALS: 24 dogs. PROCEDURE: Clinical information and results of clinicopathologic testing were obtained from medical records. Thoracic radiographs were reviewed to characterize abnormalities.
RESULTS: Dogs ranged from 1 to 10 years old at the time of diagnosis, with 12 dogs being between 1 and 3 years old. Historical complaints included cough, lameness, signs of head or neck pain, and difficulty breathing. Mild anemia, neutrophilia, and monocytosis were common. All dogs had hypoalbuminemia, and 8 of 15 had hyperglobulinemia. Thoracic radiographs of 19 dogs were reviewed. Pulmonary infiltrates were seen in 13 dogs, with an interstitial pattern of infiltration being most common. Hilar lymphadenopathy was seen radiographically in 10 dogs. Serum from 20 dogs was tested for antibodies against Coccidioides immitis. One dog was positive for IgM antibodies, 5 were positive for IgM and IgG antibodies, and 14 were positive for IgG antibodies. Quantitative IgG titers measured in 14 dogs ranged from 1:2 to 1:128 (median and mode, 1:32). In 6 dogs, histologic examination of biopsy samples revealed fungal spherules ranging from 8 to 70 microm in diameter. CONCLUSIONS AND CLINICAL RELEVANCE: Results suggest that in dogs, coccidioidomycosis may be associated with a wide spectrum of nonspecific respiratory and musculoskeletal abnormalities. The chronic nature of the disease makes diagnosis difficult, even in regions in which the organism is endemic.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12597419     DOI: 10.2460/javma.2003.222.461

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  8 in total

1.  Evaluation of Coccidioides antigen detection in dogs with coccidioidomycosis.

Authors:  Emily J Kirsch; Russell T Greene; Annalisa Prahl; Stanley I Rubin; Jane E Sykes; Michelle M Durkin; Lawrence J Wheat
Journal:  Clin Vaccine Immunol       Date:  2012-01-25

Review 2.  A review of the pathology and treatment of canine respiratory infections.

Authors:  Miranda D Vieson; Pablo Piñeyro; Tanya LeRoith
Journal:  Vet Med (Auckl)       Date:  2012-06-26

3.  Efficacy of the Investigational Antifungal VT-1161 in Treating Naturally Occurring Coccidioidomycosis in Dogs.

Authors:  Lisa F Shubitz; Michael E Roy; Hien T Trinh; William J Hoekstra; Robert J Schotzinger; Edward P Garvey
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

4.  Bicavitary eosinophilic effusion in a dog with coccidioidomycosis.

Authors:  Tara L Piech; Jared A Jaffey; Eric T Hostnik; Mary E White
Journal:  J Vet Intern Med       Date:  2020-05-24       Impact factor: 3.333

Review 5.  Preanalytical Considerations for Joint Fluid Evaluation.

Authors:  Caitlyn R Martinez; Kelly S Santangelo
Journal:  Vet Clin North Am Small Anim Pract       Date:  2016-10-05       Impact factor: 2.093

6.  Clinical performance of a point-of-care Coccidioides antibody test in dogs.

Authors:  Krystle L Reagan; Ian McHardy; George R Thompson; Jane E Sykes
Journal:  J Vet Intern Med       Date:  2021-03-06       Impact factor: 3.333

7.  Posaconazole treatment of refractory coccidioidomycosis in dogs.

Authors:  Lisa F Shubitz; Sallianne Schlacks; Polina Vishkautsan; Christine D Butkiewicz; Kate A Worthing
Journal:  J Vet Intern Med       Date:  2021-10-18       Impact factor: 3.333

8.  Δcps1 vaccine protects dogs against experimentally induced coccidioidomycosis.

Authors:  Lisa F Shubitz; Edward J Robb; Daniel A Powell; Richard A Bowen; Angela Bosco-Lauth; Airn Hartwig; Stephanie M Porter; Hien Trinh; Hilary Moale; Helle Bielefeldt-Ohmann; James Hoskinson; Marc J Orbach; Jeffrey A Frelinger; John N Galgiani
Journal:  Vaccine       Date:  2021-10-23       Impact factor: 4.169

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.